Cancers
Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell Carcinoma.
Daniel F Roadman, Daniel D Shapiro, Arighno Das, Leslie W Nelson, Paz Lotan, Michael C Risk, Kyle A Richards, Elizabeth L Koehne, David F Jarrard, Fred T Lee, Glenn O Allen, Edwarda Golden, Tim Ziemlewicz, James Louis Hinshaw, Edwin Jason Abel
Published: 202610.3390/cancers18020334
Abstract
Background/Objectives: Percutaneous microwave (MW) ablation is a nephron sparing treatment for localized renal cell carcinoma (RCC). We compared perioperative, renal functional, and oncologic outcomes for clinical stage 1 RCC treated with MW ablation…
Preview only. Read the full abstract at the source